Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel R Haynes

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|June 4, 2004
Particle-mediated DNA vaccine delivery to the skinJoel R Haynes
Expert Review of Vaccines|April 8, 2009
Influenza virus-like particle vaccinesJoel R Haynes
Expert Review of Vaccines|August 7, 2003
Needle-free epidermal powder immunizationDexiang Chen, Yuh-Fun Maa, Joel R Haynes
Current Opinion in Molecular Therapeutics|November 19, 2002
Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogmaLendon G Payne, Deborah H Fuller, Joel R Haynes
Vaccine|April 20, 2006
Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxinJoel R Haynes, Joshua Arrington, Lichun Dong, et al.
Journal of Pharmaceutical Sciences|July 30, 2010
H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizersJulian Kissmann, Sangeeta B Joshi, Joel R Haynes, et al.
Bio/Technology (Nature Publishing Company)|April 1, 2020
Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat ProteinJoel R Haynes, Janet Cunningham, Adolph von Seefried, et al.
Vaccine|September 10, 2005
Epidermal DNA vaccine for influenza is immunogenic in humansRobert J Drape, Michael D Macklin, Lori J Barr, et al.
Vaccine|April 4, 2012
Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulationsGabriel I Parra, Karin Bok, Ross Taylor, et al.
Vaccine|November 26, 2008
Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challengeJoel R Haynes, Leslie Dokken, James A Wiley, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|June 4, 2004
Particle-mediated DNA vaccine delivery to the skinJoel R Haynes
Expert Review of Vaccines|April 8, 2009
Influenza virus-like particle vaccinesJoel R Haynes
Expert Review of Vaccines|August 7, 2003
Needle-free epidermal powder immunizationDexiang Chen, Yuh-Fun Maa, Joel R Haynes
Current Opinion in Molecular Therapeutics|November 19, 2002
Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogmaLendon G Payne, Deborah H Fuller, Joel R Haynes
Vaccine|April 20, 2006
Potent protective cellular immune responses generated by a DNA vaccine encoding HSV-2 ICP27 and the E. coli heat labile enterotoxinJoel R Haynes, Joshua Arrington, Lichun Dong, et al.
Journal of Pharmaceutical Sciences|July 30, 2010
H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizersJulian Kissmann, Sangeeta B Joshi, Joel R Haynes, et al.
Bio/Technology (Nature Publishing Company)|April 1, 2020
Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat ProteinJoel R Haynes, Janet Cunningham, Adolph von Seefried, et al.
Vaccine|September 10, 2005
Epidermal DNA vaccine for influenza is immunogenic in humansRobert J Drape, Michael D Macklin, Lori J Barr, et al.
Vaccine|April 4, 2012
Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulationsGabriel I Parra, Karin Bok, Ross Taylor, et al.
Vaccine|November 26, 2008
Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challengeJoel R Haynes, Leslie Dokken, James A Wiley, et al.
Pageof 2